Cargando…

Repeatability of quantitative (18)F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis

INTRODUCTION: 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F–FLT) positron emission tomography (PET) provides a non-invasive method to assess cellular proliferation and response to antitumor therapy. Quantitative (18)F–FLT uptake metrics are being used for evaluation of proliferative response in investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kramer, G. M., Liu, Y., de Langen, A. J., Jansma, E. P., Trigonis, I., Asselin, M.-C., Jackson, A., Kenny, L., Aboagye, E. O., Hoekstra, O. S., Boellaard, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915500/ https://www.ncbi.nlm.nih.gov/pubmed/29362858 http://dx.doi.org/10.1007/s00259-017-3923-x

Ejemplares similares

Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer
por: Hoyng, Lieke L, et al.
Publicado: (2015)

Early reduction in tumour [(18)F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
por: Trigonis, Ioannis, et al.
Publicado: (2014)

Validation of [(18)F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor
por: Iqbal, R., et al.
Publicado: (2018)

Repeatability of [(18)F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
por: Kolinger, Guilherme D., et al.
Publicado: (2019)

Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
por: van Velden, Floris H. P., et al.
Publicado: (2016)

The relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models
por: Heinzmann, Kathrin, et al.
Publicado: (2016)

Correction to: The relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models
por: Heinzmann, Kathrin, et al.
Publicado: (2017)

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
por: Kolinger, Guilherme D., et al.
Publicado: (2022)

[(18)F]FDG and [(18)F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study
por: Direcks, W G E, et al.
Publicado: (2008)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Extramedullary haematopoiesis imaging with (18)F-FLT PET
por: Agool, Ali, et al.
Publicado: (2010)

Differences between [(18)F]FLT and [(18)F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
por: Burchardt, Ewa, et al.
Publicado: (2021)

Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: (18)F-FAU, (18)F-FMAU, and (18)F-FLT
por: McHugh, Christopher I., et al.
Publicado: (2016)

Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma
por: Bastiaannet, E., et al.
Publicado: (2012)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

Dual-Phase PET-CT to Differentiate [(18)F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer
por: Oprea-Lager, Daniela E., et al.
Publicado: (2012)

Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using (18)F-ICMT-11 and (18)F-FLT PET
por: Heinzmann, Kathrin, et al.
Publicado: (2018)

Quantitative parametric maps of O-(2-[(18)F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma
por: Koopman, Thomas, et al.
Publicado: (2019)

The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
por: Lim, Sung Hee, et al.
Publicado: (2016)

(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors
por: Desar, Ingrid M. E., et al.
Publicado: (2012)

Quantitative Assessment of Bone Marrow Activity Using (18)F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes
por: Tasaki, Toshiki, et al.
Publicado: (2022)

(18)F-FLT PET/CT in Patients with Gastric Carcinoma
por: Małkowski, Bogdan, et al.
Publicado: (2013)

Intratumoral (18)F-FLT infusion in metabolic targeted radiotherapy
por: Tippayamontri, Thititip, et al.
Publicado: (2019)

In-vivo Comparison of (18)F-FLT uptake, CT Number, Tumor Volume in Evaluation of Repopulation during Radiotherapy for Lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Evaluation of factors influencing (18)F-FET uptake in the brain
por: Verger, Antoine, et al.
Publicado: (2017)

Limits of [(18)F]-FLT PET as a Biomarker of Proliferation in Oncology
por: McKinley, Eliot T., et al.
Publicado: (2013)

Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
por: Pfaehler, Elisabeth, et al.
Publicado: (2021)

(18)F-FDG-PET uptake in non-infected total hip prostheses
por: Gelderman, Stefan J, et al.
Publicado: (2018)

Glucose–Thymidine Ratio as a Metabolism Index Using (18)F-FDG and (18)F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy
por: Oh, Sera, et al.
Publicado: (2022)

Evaluation of limited blood sampling population input approaches for kinetic quantification of [(18)F]fluorothymidine PET data
por: Contractor, Kaiyumars B, et al.
Publicado: (2012)

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma
por: Costantini, Danny L., et al.
Publicado: (2016)

Test–retest repeatability of [(18)F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals
por: Timmers, Tessa, et al.
Publicado: (2019)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repair
por: Wondergem, Marielle J, et al.
Publicado: (2014)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Effect of Shortening the Scan Duration on Quantitative Accuracy of [(18)F]Flortaucipir Studies
por: Tuncel, Hayel, et al.
Publicado: (2021)

PET Cell Tracking Using (18)F-FLT is Not Limited by Local Reuptake of Free Radiotracer
por: MacAskill, Mark G., et al.
Publicado: (2017)

(18) F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma
por: Jansen, Marc H A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nvebc8dsmcjnvkfb87bvkek7dh